8
Total investments
2
Early stage
3
Mid stage
2
Late stage
9y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2022
Founded in 2018, Abridge is the first AI-native clinician intelligence platform organized around the patient, built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based decisions for every moment of care. Powered by purpose-built AI for healthcare, Abridge connects patients, providers, payers, and life sciences companies. This year, the platform will support more than 100 million patient-clinician conversations across 300 of the largest and most complex health systems in the U.S. With deep EHR integration, Abridge’s automatic speech recognition and note generation has been validated to capture encounters in 28+ languages across specialties and care settings.
Abridge is setting the industry standard for the responsible deployment of AI across health systems. Features like Linked Evidence map AI-generated clinical documentation to source data, helping clinicians quickly trust and verify the output.
Abridge was awarded Best in KLAS for Ambient AI in 2025 and 2026, in addition to other accolades, including TIME Best Inventions of 2024 and 2025, CNBC Disruptor 2025, and Fast Company’s Most Innovative Companies 2025.
Investor
Jun 2021
Arcaea (Ar-kay-uh). Were on a mission to build a new foundation for the beauty industry where biology as the creative tool for self-expression. Were growing new ingredients and product experiences for beauty through technology that includes DNA sequencing, biological engineering, fermentation and more. By culturing industry-leading, safe, and sustainable ingredients, we intend to create a new supply chain for the industry that does not rely on petrochemicals or on harvesting and depleting natural resources while making products that can deliver new functionality and performance across skincare, bodycare, haircare, and aesthetics. Arcaea was incubated on the Ginkgo Bioworks platform under the working title Kalo.
Investor
Jun 2021
Motif FoodWorks is creating the next generation of delicious food. We are a food technology company developing breakthrough ingredients that unleash the promise of plant-based foods and transform the eating experience – from first bite to lasting impact. With food as our passion and innovation coded into our DNA, we are driven by the science of more. More taste. More texture. More choices for consumers. That is why our work has gone beyond the lab. We have taken it all the way to the plate with products grown from the universal experience of what great food should be: tantalizing, satiating, and nourishing. Our ecosystem of ingredients and finished products are designed for people of all habits and beliefs and with the health of our planet always in mind. Because at Motif, we believe the food of the future should set you free.
Find out more at madewithmotif.com.
Investor
Feb 2021
Our mission is to provide unprecedented access to blood testing.
We enable sustainable healthcare with accessible blood testing for a healthier you.
Investor
May 2020
The leading digital experience platform helping you to meet your growing demand for engaging, personalized content at scale. We enable dynamic personalization, automated content delivery, and real-time experimentation, powering next-generation digital experiences across the globe.
🟡 Create and manage content from anywhere to go everywhere with Contentful Platform: https://ctfl.io/4aDVheL
🔵 Let anyone assemble on-brand experiences at scale with Contentful Studio: https://ctfl.io/3UV8N7U
🔴 Easily compose your own best-in-class platform with Contentful Ecosystem: https://ctfl.io/4e37KLN
Join our Developer Community on Discord: https://www.contentful.com/discord/
Work for our distributed team around the world: https://ctfl.io/3sznz6y
Investor
May 2020
Thirty Madison exists to deliver on healthcares biggest opportunities: access and affordability; patient outcomes; and patient experience. With empathy at the heart of its innovation, its proprietary care model empowers hundreds of thousands of people with ongoing conditions with accessible, effective treatments across a lifetime of care. Learn more at ThirtyMadison.com.
Experience · 11 entries
All (11)
Investments (8)
2022
Investor
Mar 2022
Founded in 2018, Abridge is the first AI-native clinician intelligence platform organized around the patient, built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based decisions for every moment of care. Powered by purpose-built AI for healthcare, Abridge connects patients, providers, payers, and life sciences companies. This year, the platform will support more than 100 million patient-clinician conversations across 300 of the largest and most complex health systems in the U.S. With deep EHR integration, Abridge’s automatic speech recognition and note generation has been validated to capture encounters in 28+ languages across specialties and care settings.
Abridge is setting the industry standard for the responsible deployment of AI across health systems. Features like Linked Evidence map AI-generated clinical documentation to source data, helping clinicians quickly trust and verify the output.
Abridge was awarded Best in KLAS for Ambient AI in 2025 and 2026, in addition to other accolades, including TIME Best Inventions of 2024 and 2025, CNBC Disruptor 2025, and Fast Company’s Most Innovative Companies 2025.
2021
Investor
Jun 2021
Arcaea (Ar-kay-uh). Were on a mission to build a new foundation for the beauty industry where biology as the creative tool for self-expression. Were growing new ingredients and product experiences for beauty through technology that includes DNA sequencing, biological engineering, fermentation and more. By culturing industry-leading, safe, and sustainable ingredients, we intend to create a new supply chain for the industry that does not rely on petrochemicals or on harvesting and depleting natural resources while making products that can deliver new functionality and performance across skincare, bodycare, haircare, and aesthetics. Arcaea was incubated on the Ginkgo Bioworks platform under the working title Kalo.
Investor
Jun 2021
Motif FoodWorks is creating the next generation of delicious food. We are a food technology company developing breakthrough ingredients that unleash the promise of plant-based foods and transform the eating experience – from first bite to lasting impact. With food as our passion and innovation coded into our DNA, we are driven by the science of more. More taste. More texture. More choices for consumers. That is why our work has gone beyond the lab. We have taken it all the way to the plate with products grown from the universal experience of what great food should be: tantalizing, satiating, and nourishing. Our ecosystem of ingredients and finished products are designed for people of all habits and beliefs and with the health of our planet always in mind. Because at Motif, we believe the food of the future should set you free.
Find out more at madewithmotif.com.
Investor
Feb 2021
Our mission is to provide unprecedented access to blood testing.
We enable sustainable healthcare with accessible blood testing for a healthier you.
Show all 11 entries ↓
Investment activity
2017–2022 · 8 investments
Recent (last 2 years)Earlier
